China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SHE:000999)
China flag China · Delayed Price · Currency is CNY
25.00
-0.55 (-2.15%)
Jul 21, 2026, 3:06 PM CST

SHE:000999 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
30,69730,49426,46623,83717,41114,825
Other Revenue
1,1091,1091,151901.47667.99719.33
31,80631,60327,61724,73918,07915,544
Revenue Growth (YoY)
12.31%14.43%11.63%36.84%16.31%13.98%
Cost of Revenue
14,56714,56713,45211,6758,3546,561
Gross Profit
17,23917,03614,16413,0649,7258,984
Selling, General & Admin
10,96810,9688,8608,4896,1355,992
Research & Development
1,2681,268801.75714.5593.94560.2
Other Operating Expenses
659.64334.16229.73262.72207.05204.39
Operating Expenses
12,93212,6069,9749,5216,9426,770
Operating Income
4,3074,4304,1913,5432,7842,214
Interest Expense
-117.62-117.62-80.04-80.78-21.23-14.18
Interest & Investment Income
90.3290.32133.9125.1118.11101.08
Currency Exchange Gain (Loss)
-2.75-2.755.482.5-56.25-12.89
Other Non Operating Income (Expenses)
-1.48-32.7-15.21-17.44-4.11-1.11
EBT Excluding Unusual Items
4,2764,3674,2353,5722,8202,287
Impairment of Goodwill
-----65.51-44.24
Gain (Loss) on Sale of Investments
227.41227.4168.2-28.632.585.04
Gain (Loss) on Sale of Assets
6.56.531.430.812.280.85
Asset Writedown
-50.18-50.18-19.67-82.35-34.3-8.1
Other Unusual Items
312.99312.99278.8292.43237.69202.96
Pretax Income
4,7734,8644,5943,7542,9632,444
Income Tax Expense
750.18698.12815.87580.97466.43345.41
Earnings From Continuing Operations
4,0234,1663,7783,1732,4972,099
Minority Interest in Earnings
-744.96-744.96-409.85-320.55-48.21-43.49
Net Income
3,2783,4213,3682,8532,4492,055
Net Income to Common
3,2783,4213,3682,8532,4492,055
Net Income Growth
17.70%1.58%18.05%16.50%19.16%28.65%
Shares Outstanding (Basic)
1,6641,6611,6671,6561,6691,654
Shares Outstanding (Diluted)
1,6641,6611,6671,6631,6691,654
Shares Change (YoY)
-0.04%-0.40%0.25%-0.33%0.90%-0.15%
EPS (Basic)
1.972.062.021.721.471.24
EPS (Diluted)
1.972.062.021.721.471.24
EPS Growth
17.75%1.98%17.76%16.89%18.10%28.83%
Free Cash Flow
-4,2423,6123,3352,0551,012
Free Cash Flow Per Share
-2.552.172.001.230.61
Dividend Per Share
0.5901.0401.0150.8870.5920.505
Dividend Growth
-59.74%2.42%14.41%49.99%17.26%70.53%
Gross Margin
54.20%53.91%51.29%52.81%53.79%57.79%
Operating Margin
13.54%14.02%15.17%14.32%15.40%14.24%
Profit Margin
10.30%10.82%12.20%11.53%13.54%13.22%
Free Cash Flow Margin
-13.42%13.08%13.48%11.37%6.51%
EBITDA
5,4035,4604,8294,2283,2512,643
EBITDA Margin
16.99%17.28%17.48%17.09%17.98%17.00%
D&A For EBITDA
1,0961,030638.08685.71467.17429.17
EBIT
4,3074,4304,1913,5432,7842,214
EBIT Margin
13.54%14.02%15.17%14.32%15.40%14.24%
Effective Tax Rate
15.72%14.35%17.76%15.47%15.74%14.13%
Revenue as Reported
31,60331,60327,61724,73918,07915,544
Advertising Expenses
-1,316754.25660.33543.92578.72